NCT05890950: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
- State
- Completed
- Phase
- Phase 1
- People
- 24 taking part
- Started
- 13 Mar 2023
- Primary completion
- 12 Jul 2023
- Arms
- K-757 and K-833 combination
- Results
- None posted
- 13 Mar 2023: Trial started
- 6 Jun 2023: Trial registered
- 12 Jul 2023: Trial completed